New hope for tough pancreatic cancer: immunotherapy combo trial shows promise
Disease control
Completed
This early-phase trial tested combinations of immunotherapy drugs with standard chemotherapy in 45 people whose pancreatic cancer had spread. The goal was to see if these combos are safe and help shrink tumors. While not a cure, the study aims to improve disease control for this …
Phase: PHASE1 • Sponsor: Cancer Insight, LLC • Aim: Disease control
Last updated May 05, 2026 11:53 UTC